AOD-9604, short for Anti-Obesity Drug-9604, is a synthetic analog of the human growth hormones lipolytic (fat-burning) region
A significant finding is its effect in pathological scarring models, such as keloids, where it promoted apoptosis in resistant fibroblasts and reduced cell proliferation during the G0/G1 phase of the cell cycle
April 15, 2026: In the updated 503A document, the FDA announced it is removing BPC-157 (both BPC-157 acetate and BPC-157 free base) from Category 2 and scheduling a PCAC meeting for July 23, 2026
Aging Cell 2014;13, 379390, doi: He, W
Do you have everything you need
GHK-Cu should be used under medical supervision